Herceptin linked to doubling of HF risk in women with breast cancerAugust 6, 2018Breast CancerPreventive Care
PI3K inhibitor/fulvestrant has modest benefit, serious toxicity in breast cancerJune 3, 2018Breast Cancer
TAILORx: Most women with intermediate risk ER+ breast cancer can safely skip chemoJune 3, 2018Breast Cancer
Ketorolac may reduce breast cancer recurrence risk, particularly in overweight patientsMay 25, 2018Breast Cancer
Breast cancer: More pathogenic variants detected as multiple-gene sequencing takes overMay 11, 2018Breast Cancer
Universal BRCA testing worthwhile for relatives of high-grade serous ovarian cancer patientsApril 28, 2018Gynecologic CancerBreast CancerPreventive Care
